logo

IMDX

Insight Molecular·NASDAQ
--
--(--)
--
--(--)
4.05 / 10
Netural

Fundamental analysis of IMDX shows a balanced setup: strong gross profit margin (61.797%) and positive Profit-MV (0.4743) indicate solid profitability, yet a high PB-ROE (1.1372) and negative Fixed assets turnover ratio (0.4552) hint at inefficiencies. Revenue-MV (-4.2825) and Cash-MV (-0.0663) are below peers, suggesting growth and liquidity headwinds. Net income-Revenue (-0.1516) further underscores margin compression risks. Composite outlook: prudent with a neutral rating.

Fundamental(4.05)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value-4.28
Score2/3
Weight21.09%
1M Return11.31%
Inventory turnover ratio
Value2.53
Score2/3
Weight-3.32%
1M Return-2.37%
Gross profit margin (%)
Value61.80
Score2/3
Weight2.31%
1M Return1.40%
Profit-MV
Value0.47
Score2/3
Weight14.54%
1M Return7.95%
Net income-Revenue
Value-0.15
Score2/3
Weight14.74%
1M Return8.04%
PB-ROE
Value1.14
Score0/3
Weight7.46%
1M Return4.05%
Current assets turnover ratio
Value0.18
Score1/3
Weight0.40%
1M Return0.27%
Fixed assets turnover ratio
Value0.46
Score1/3
Weight-1.92%
1M Return-1.34%
Asset-MV
Value-0.51
Score3/3
Weight30.31%
1M Return14.63%
Cash-MV
Value-0.07
Score2/3
Weight14.40%
1M Return7.78%
Is IMDX undervalued or overvalued?
  • IMDX scores 4.05/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, -1380.69% net margin, -3.31 P/E ratio, -22.82 P/B ratio, and 27.54% earnings growth, these metrics solidify its Netural investment rating.